Previous Article | Next Article ![]()
Journal of Virology, November 2000, p. 10796-10800, Vol. 74, No. 22
Lady Davis Institute for Medical Research and
McGill AIDS Centre, Jewish General Hospital,1
and Departments of Microbiology and
Immunology2 and
Medicine,3 McGill University,
Montreal, Quebec, Canada H3T 1E2
Received 11 May 2000/Accepted 4 August 2000
To study in vivo tRNA3Lys genomic placement
and the initiation step of reverse transcription in human
immunodeficiency virus type 1, total viral RNA isolated from either
wild-type or protease-negative (PR The initial stages of human
immunodeficiency virus type 1 (HIV-1) assembly involve the interaction
of the precursor protein Pr55gag with itself and
with Pr160gag-pol. During or after budding,
Pr55gag is cleaved by viral protease to the
mature viral proteins, which include matrix, capsid, nucleocapsid, and
p6; Pr160gag-pol is cleaved by viral protease
into matrix, capsid, nucleocapsid, and the viral enzymes protease,
reverse transcriptase (RT), and integrase (20). Viral
genomic RNA (1) and cellular tRNALys
(15) are also selectively packaged into the virus during
assembly of the precursor proteins. One of the tRNALys
isoacceptors, tRNA3Lys, binds to the primer binding
site (PBS) on the genomic RNA, where it acts as the primer for
initiation of reverse transcription. Both the selective incorporation
of tRNA3Lys (17) and its placement onto the
PBS (12) occur independently of precursor protein
processing, and work has shown that while Pr160gag-pol is required for selective packaging
of tRNA3Lys into Pr55gag
particles (17), Pr55gag plays a major
role in placing tRNA3Lys onto the PBS (3,
6).
While primer tRNA interacts with the PBS via the 3'-terminal 18 nucleotides of the primer tRNA, chemical and enzymatic probing and
computer modeling indicate that additional interactions occur between
regions upstream of the HIV-1 PBS and the D, T Figure 1A shows the first six
deoxyribonucleotides incorporated during reverse transcription in
HIV-1. We have previously reported that primer
tRNA3Lys exists on the HIV-1 genome both in an
unextended form and as a tRNA extended by two deoxynucleotides
(12). In that work, total viral RNA was used as the source
of primer/template in an in vitro reverse transcription reaction, in
the presence of a single radioactive nucleotide.
tRNA3Lys was shown to be extended one base when
[
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Roles of Pr55gag and NCp7 in
tRNA3Lys Genomic Placement and the Initiation Step
of Reverse Transcription in Human Immunodeficiency Virus
Type 1
![]()
ABSTRACT
Top
Abstract
Text
References
) virus was used as the
source of primer tRNA3Lys/genomic RNA templates
in an in vitro reverse transcription assay. At low dCTP concentrations,
both the rate and extent of the first nucleotide incorporated into
tRNA3Lys, dCTP, were lower with PR
than
with wild-type total viral RNA. Transient in vitro exposure of either
type of primer/template RNA to NCp7 increased PR
dCTP
incorporation to wild-type levels but did not change the level of
wild-type dCTP incorporation. Exposure of either primer/template to
Pr55gag had no effect on initiation. These
results indicate that while Pr55gag is
sufficient for tRNA3Lys placement onto the genome,
exposure of this complex to mature NCp7 is required for optimum
tRNA3Lys placement and initiation of reverse transcription.
![]()
TEXT
Top
Abstract
Text
References
C, and anticodon loops
of tRNA3Lys (13, 14). It is thus likely that
extensive denaturation of tRNA3Lys, as well as the
genomic RNA region containing the PBS, occurs during and after
its placement onto the viral RNA genome. In HIV-1, mature nucleocapsid
protein NCp7 facilitates the in vitro annealing of
tRNA3Lys to in vitro-transcribed genomic RNA
sequence (5), probably by unwinding the secondary structure
of tRNA3Lys in vitro (16), and the stem-loop
structures in the PBS area of the genomic RNA (14).
Nevertheless, genomic placement of tRNA3Lys
onto the PBS in vivo does not require precursor proteolysis
(12). Although mature NCp7 does not appear to be required
for the initial genomic placement of tRNA3Lys,
we provide evidence in this work that it does optimize the final placement of the primer tRNA3Lys onto the PBS.
-32P]dCTP was used, indicating the presence of
unextended tRNA3Lys placed on the genome. A
three-base-extended tRNA3Lys was detected when
[
-32P]dGTP was used, indicating the presence of
two-base-extended tRNA3Lys placed on the genome
(12). No radioactive nucleotide incorporation into
tRNA3Lys was detected when either
[
-32P]dATP or [
-32P]dTTP was
used alone.

View larger version (34K):
[in a new window]
FIG. 1.
Initiation of in vitro reverse transcription primed by
wild-type total viral RNA using either [
-32P]dGTP
(three-base extension of tRNA3Lys) or
[
-32P]dCTP (one-base extension of
tRNA3Lys. (A) Diagram showing the first six dNTPs
incorporated into tRNA3Lys during the initiation of
reverse transcription. (B) 1D PAGE of tRNA3Lys
extension products. Shown is the ability of tRNA3Lys to
be extended in the presence of a single dNTP in an in vitro RT reaction
primed by wild-type total viral RNA. The single dNTP used is either
[
-32P]dCTP (lanes a and c) or
[
-32P]dGTP (lanes b and d). (C to F) Dependence of
synthesis tRNA3Lys extension products on time (C and D)
and dNTP substrate concentration (E and F). Products were resolved
by 1D PAGE and quantitated by phosphorimaging. (C) Time courses of dGTP
incorporation onto tRNA3Lys at 0.16 (
) and 5.0 (
)
µM dGTP, as normalized to maximum incorporation of dGTP at 5 µM
dGTP. (D) Time courses of incorporation of dCTP onto
tRNA3Lys at 0.16 (
) and 5.0 (
) µM dCTP, as
normalized to maximum incorporation of dCTP at 5.0 µM dCTP. (E)
Dependence of dGTP incorporation on dGTP substrate concentration,
normalized to maximum dGTP incorporation. Reverse transcription was for
30 min. (F) Dependence of dCTP incorporation on dCTP substrate
concentration, normalized to maximum dCTP incorporation. Reverse
transcription was for 30 min.
At low deoxyribonucleotide concentrations, the incorporation of
dCTP into unextended tRNA3Lys shows a greater
dependency on the concentration of dCTP than does the
incorporation of dGTP into two-base-extended
tRNA3Lys. The one-dimensional polyacrylamide gel
electrophoresis (1D PAGE) data in Fig. 1B show the
tRNA3Lys extension products resulting from an in vitro
reverse transcription reaction using total wild-type BH10 viral RNA as
the source of primer/template in the presence of a single radioactive
nucleotide, either [
-32P]dCTP or
[
-32P]dGTP. The transfection of COS7 cells with
HIV-1 proviral DNA, isolation of virions and total viral RNA, use of
total viral RNA as the source of primer tRNA3Lys
genomic RNA template in an in vitro reverse transcription
system, and 1D PAGE analysis of the reaction products were as
previously described (11, 12). Equal amounts of
genomic RNA were used in the reaction, with the amount of
genomic RNA in the total viral RNA sample determined by
dot blot hybridization with a genomic RNA probe
(18). Total viral RNA was incubated at 37°C in 20 µl of RT buffer (50 mM Tris-HCl [pH 7.5], 60 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol) containing 50 ng of purified
HIV RT, 10 U of RNasin, and various radioactive
-32P-labeled deoxynucleoside triphosphates (dNTPs). The
extension product was ethanol precipitated, resuspended, and analyzed
on 6% polyacrylamide-7 M urea-1× Tris-borate-EDTA. The data in Fig. 1B indicate that the unextended and two-base-extended
tRNA3Lys are at approximately equal concentrations when
reverse transcription is carried out at a deoxyribonucleotide substrate
concentration of 0.16 µM; at 5.0 µM, approximately 75% of the
placed tRNA3Lys is unextended, while 25% is two-base
extended. As shown in Fig. 1C to F, this difference appears to be due
to a lower association constant for dCTP than for dGTP. While dGTP
substrate concentrations of 0.16 and 5.0 µM do not affect the time
course for the dGTP reaction (Fig. 1C), both the rate and extent of
dCTP incorporation are significantly lower when the reaction is carried
out at 0.16 rather than 5.0 µM (Fig. 1D). Similarly, there is little
difference in the extent of incorporation of dGTP when substrate dGTP
concentrations of 0.16 and 5.0 µM are used (Fig. 1E), while there is
a more than threefold difference in the extents of incorporation
between the dCTP incorporated at substrate dCTP concentrations of 0.16 and 5.0 µM. These data indicate that the incorporation of dGTP onto tRNA3Lys appears to have a higher association constant
than dCTP incorporation. While this could reflect differences
in base position (1 versus 3) in the cDNA extension of primer
tRNA3Lys, it is more likely due to differences in
dNTPs, since it had been reported that in an in vitro reverse
transcription system, the KM for a dCTP/HIV-1 RT
reaction (3.3 µM) was 10-fold greater than that than for a dGTP/HIV-1
RT reaction (0.33 µM) (9).
The data shown in Fig. 2 indicate that
both the rate and extent of incorporation of the first dCTP into
tRNA3Lys are lower when tRNA3Lys
is placed onto the viral genome in a protease-negative
(PR
) virus rather than in a wild-type virus. Total viral
RNA from either type of virus was used as the source of primer/template in the in vitro RT reaction mixture containing different concentrations of [
-32P]dCTP. Equal amounts of unextended
tRNA3Lys, as determined by the amount of reaction
product at 5.0 µM dCTP, were used in each reaction mixture. Wild-type
genomic RNA contains both unextended and
two-base-extended tRNA3Lys, while PR
viruses do not contain detectable extended tRNA3Lys
(12). We have thus found that in reactions used herein,
which contain equal amounts of unextended tRNA3Lys, the
PR
primer/template RNA generally contains 10 to 20% less
genomic RNA than is found for wild-type primer/template RNA,
reflecting the presence of two-base-extended tRNA3Lys
on some wild-type primer/template RNAs.
|
Figure 2 shows the rate and extent of the incorporation of the
first-base dCTP onto unextended tRNA3Lys, using as the
source of primer/template total viral RNA isolated from either
wild-type or PR
virus. At lower dCTP concentrations, the
rate and extent of dCTP incorporation into tRNA3Lys are
lower with PR
than with wild-type primer/template RNA
(Fig. 2A to C). The reactions in Fig. 1C were carried out for 30 min,
at which time the reaction was complete, as shown in Fig. 1D by the
time courses for these reactions using both primer/tRNA templates at
three different dCTP concentrations. The results in Fig. 2 indicate
that the primer tRNA3Lys interaction with the
genomic RNA in a PR
virion is different from that
found for tRNA3Lys placed in a wild-type virion.
We next investigated the possibility that as a result of
Pr55gag proteolytic processing, mature NCp7
may alter the conformation of the primer/template complex, thereby
enhancing the amount of reaction between dCTP and primer
tRNA3Lys (Fig. 3). The
72-amino-acid HIV-1 NCp7 peptide used in this analysis was
prepared by solid-phase chemical synthesis as previously described (4). Plasmid pGST-Gag, which codes for a
glutathione-S-transferase (GST)-Gag fusion protein, was a
kind gift from Michelle Bouyac. It was used to synthesize GST-Gag
in Escherichia coli, and the protein was isolated from the
bacterial lysate using glutathione-agarose beads as previously
described (2). After exposure of primer/template RNA to the
protein, the NCp7 or Pr55gag was removed by
proteinase K digestion and phenol-chloroform extraction. Then reverse
transcription was initiated through the addition of RT, and the
reaction mixture was incubated for 30 min.
|
In the presence of 0.16 µM dCTP (Fig. 3A) and in the absence of
prior exposure of the primer/template RNA to nucleocapsid protein,
incorporation of dCTP by wild-type primer/template was 2.5 times
greater than that for PR
primer/template RNA.
Exposure of the wild-type primer/template complex to 2 and 10 pmol of NCp7 had little effect on dCTP incorporation, but similar
exposure of the PR
primer/template RNA to NCp7 resulted
in a two- and threefold increases in dCTP incorporation, respectively,
reaching levels obtained using wild-type primer/template RNA. Removal
of the added NCp7 with phenol-chloroform before use of the
primer/template RNA in reverse transcription indicated that NCp7 acts
by producing a stable alteration in the
tRNA3Lys/genomic RNA conformation that cannot
be produced by Pr55gag alone (Fig. 3C). This
could involve alterations in the conformation of either
genomic RNA, tRNA3Lys, or both. Differences in
the thermostability of murine and HIV-1 genomic RNA dimers
isolated from wild-type and PR
viruses have also been
reported (7, 8).
This effect of NCp7 on increasing dCTP incorporation into
tRNA3Lys was also examined using RT reaction mixtures
containing 5.0 µM dCTP (Fig. 3B). We showed in Fig. 2 that in the
presence of 5.0 µM dCTP, dCTP incorporation was maximum and similar
using either wild-type or PR
virus. Exposure of either
wild-type or PR
primer/template RNA to NCp7 had no
further effect on dCTP incorporation at 5.0 µM dCTP, unlike
the effect seen with 0.16 µM dCTP (Fig. 3A). This indicates that the
amount of tRNA3Lys placed on either genomic RNA
is maximal under these conditions (5.0 µM dCTP) and that the exposure
of these templates to NCp7 does not facilitate further in vitro
annealing of primer tRNA3Lys.
This was further examined by directly measuring total placement of
extendable tRNA3Lys in the absence and presence of
exposure of primer/template RNA to NCp7 (Fig. 3D). The RT reaction
mixture contained non-rate-limiting amounts of 200 µM dCTP and 200 µM dTTP, plus 10 µCi of [
-32P]dGTP (0.16 µM). The replacement of dATP with 50 µM ddATP terminated the
DNA extension product of unextended and two-base-extended tRNA3Lys at six bases (Fig. 1A). The reactions shown in
Fig. 3D used equal amount of unextended tRNA3Lys, which
accounts for the fact that total synthesis using wild-type primer/template RNA was about 25% higher than that using
PR
primer/template RNA, since only the former had
two-base-extended tRNA3Lys as well as unextended
tRNA3Lys. It can be seen that there was little change
in the total placement of tRNA3Lys upon addition
of NCp7 to either primer/template RNA type.
According to the model presented,
Pr55gag can place tRNA3Lys
onto the viral genome, but mature NCp7 may be required to
configure this interaction for optimum priming. If this is so, then the prior exposure of a PR
primer/template RNA to
Pr55gag should not increase initiation of
reverse transcription at low dCTP concentrations, as is found when NCp7
is added. The data in Fig. 3C indicate that this is true. Various
amounts of Pr55gag protein (0.5 and 2.5 pmol) were preincubated with primer/template complex in RT buffer
at 37°C for 30 min. The Pr55gag protein
was removed by proteinase K digestion and phenol-chloroform extraction,
as described above, before initiation of the one-base RT
extension reaction. The data in Fig. 3C show that
Pr55gag does not increase initiation from
tRNA3Lys placed on the genome in either wild-type or
PR
virions. Since tRNA3Lys placement has
been shown to be facilitated both in vitro (6) and in vivo
(3) by Pr55gag, this also
indicates that the NCp7-facilitated increase in dCTP incorporation into
tRNA3Lys using the PR
primer/template at
a low dCTP concentration is not the result of increased in vitro
placement of tRNA3Lys onto the template.
The differences observed for wild-type and PR
primer/templates in the rate and extent of initiation of reverse
transcription may reflect differences in affinity of dCTP for a
conformationally altered RT or primer tRNA3Lys.
Current evidence indicates that during the initiation of reverse transcription, RT binds first to the primer tRNA/template complex and then to the dNTP (10, 19). It is therefore
possible that differences in the conformations between the wild-type
and PR
primer tRNA/template complexes can induce
correspondingly different conformations of the RT binding to
these complexes, thereby affecting the affinity of the enzyme for dCTP.
This phenomenon has been reported for artificial primer/templates. For
example, it was found that the reaction between dCTP and HIV-1 RT using
poly(rI)-oligo(dC) had a KM of 12.2 µM, while
the same reaction using a heteropolymeric primer/template had a
KM of 3.3 µM (9).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada H3T 1E2. Phone: (574) 340-8260. Fax: (574) 340-7502. E-mail: md26{at}musica.mcgill.ca.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218[Medline]. |
| 2. | Bouyac, M., M. Courcoul, G. Bertoia, Y. Baudat, D. Gabuzda, D. Blanc, N. Chazal, P. Boulanger, J. Sire, R. Vigne, and B. Spire. 1997. Human immunodeficiency virus type 1 Vif protein binds to the Pr55gag precursor. J. Virol. 71:9358-9365[Abstract]. |
| 3. |
Cen, S.,
Y. Huang,
A. Khorchid,
J. L. Darlix,
M. A. Wainberg, and L. Kleiman.
1999.
The role of Pr55gag in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA.
J. Virol.
73:4485-4488 |
| 4. | De Rocquigny, H., D. Ficheux, M. C. Fournie-Zaluski, J. L. Darlix, and B. Roques. 1991. First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form. Biochem. Biophys. Res. Commun. 180:1010-1018[CrossRef][Medline]. |
| 5. |
De Rocquigny, H.,
C. Gabus,
A. Vincent,
M.-C. Fournie-Zaluski,
B. Roques, and J.-L. Darlix.
1992.
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.
Proc. Natl. Acad. Sci. USA
89:6472-6476 |
| 6. |
Feng, Y. X.,
S. Campbell,
D. Harvin,
B. Ehresmann,
C. Ehresmann, and A. Rein.
1999.
The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.
J. Virol.
73:4251-4256 |
| 7. |
Fu, W.,
R. J. Gorelick, and A. Rein.
1994.
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
J. Virol.
68:5013-5018 |
| 8. |
Fu, W., and A. Rein.
1993.
Maturation of dimeric viral RNA of Moloney murine leukemia virus.
J. Virol.
67:5443-5449 |
| 9. |
Gu, Z.,
R. S. Fletcher,
E. J. Arts,
M. A. Wainberg, and M. A. Parniak.
1994.
The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2',3'- dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
J. Biol. Chem.
269:28118-28122 |
| 10. |
Hsieh, J.,
S. Zinnen, and P. Modrich.
1993.
Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase.
J. Biol. Chem.
268:24607-24613 |
| 11. |
Huang, Y.,
A. Khorchid,
J. Gabor,
J. Wang,
X. Li,
J. L. Darlix,
M. A. Wainberg, and L. Kleiman.
1998.
The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA3Lys genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.
J. Virol.
72:3907-3915 |
| 12. | Huang, Y., J. Wang, A. Shalom, Z. Li, A. Khorchid, M. A. Wainberg, and L. Kleiman. 1997. Primer tRNA3Lys on the viral genome exists in unextended and two base-extended forms within mature human immunodeficiency virus type 1. J. Virol. 71:726-728[Abstract]. |
| 13. | Isel, C., C. Ehresmann, G. Keith, B. Ehresmann, and R. Marquet. 1995. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNALys3 (template/primer) complex. J. Mol. Biol. 247:236-250[CrossRef][Medline]. |
| 14. |
Isel, C.,
R. Marquet,
G. Keith,
C. Ehresmann, and B. Ehresmann.
1993.
Modified nucleotides of tRNALys3 modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription.
J. Biol. Chem.
268:25269-25272 |
| 15. |
Jiang, M.,
J. Mak,
A. Ladha,
E. Cohen,
M. Klein,
B. Rovinski, and L. Kleiman.
1993.
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.
J. Virol.
67:3246-3253 |
| 16. |
Khan, R., and D. P. Giedroc.
1992.
Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA.
J. Biol. Chem.
267:6689-6695 |
| 17. |
Mak, J.,
M. Jiang,
M. A. Wainberg,
M.-L. Hammarskjold,
D. Rekosh, and L. Kleiman.
1994.
Role of Pr160gag-pol in mediating the selective incorporation of tRNALys into human immunodeficiency virus type 1 particles.
J. Virol.
68:2065-2072 |
| 18. | Mak, J., A. Khorchid, Q. Cao, Y. Huang, I. Lowy, M. A. Parniak, V. R. Prasad, M. A. Wainberg, and L. Kleiman. 1997. Effects of mutations in Pr160gag-pol upon tRNALys3 and Pr160gag-pol incorporation into HIV-1. J. Mol. Biol. 265:419-431[CrossRef][Medline]. |
| 19. | Patel, P. H., A. Jacobo-Molina, J. Ding, C. Tantillo, A. D. Clark, R. Raag, R. G. Nanni, S. H. Hughes, and E. Arnold. 1995. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34:5351-5363[CrossRef][Medline]. |
| 20. | Swanstrom, R., and J. W. Wills. 1997. Synthesis, assembly, and processing of viral proteins, p. 263-334. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»